US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ODDITY Tech Ltd.

72.28

-1.7150-2.32%

Post-market: 72.280.00000.00%17:54 EDT

Volume:858.72K

Turnover:62.11M

Market Cap:4.03B

PE:41.61

High:73.86

Open:72.50

Low:71.08

Close:73.99

Loading ...

Overview Company News Filings

ODDITY Tech Reports $103 Million Remaining in $150 Million Share Buyback Authorization

MT Newswires Live

Earnings Flash (ODD) ODDITY Tech Q4 Revenue of $123.6 Million vs. FactSet Est $119.6 Million

MT Newswires Live

Oddity Tech (ODD) Tops Q4 Earnings and Revenue Estimates

Oddity Tech Ltd reports results for the quarter ended December 31 - Earnings Summary

Earnings Flash (ODD) ODDITY Tech Q4 Adjusted EPS $0.20 vs. FactSet Est EPS of $0.13

MT Newswires Live

Oddity sees FY25 EPS $1.94-$1.98, consensus $1.73

Stock Track | ODDITY Tech Soars 5.89% After Record Q4 Revenue and Profits

ODDITY Tech Q4 2024 Adj EPS $0.20 Beats $0.13 Estimate, Sales $124.00M Beat $119.63M Estimate

Oddity Tech: Q4 Earnings Snapshot

Associated Press Finance

Oddity Tech Outlook FY Adjusted EPS USD 1.94-1.98

THOMSON REUTERS

Oddity Tech Q4 Gross Margin 72.7%

THOMSON REUTERS

IPO Stock Of The Week: AI Leader Oddity Shows Buy Point Ahead Of Q4 Earnings

US Stocks That Might Be Trading At A Discount In February 2025

Simply Wall St.

Top Growth Companies With High Insider Ownership On US Exchanges February 2025

Simply Wall St.

ODDITY to Announce Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Rare opportunities – ASX health stocks tackling unmet medical needs

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia

Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis

Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma

INmune Bio Announces Plan to Submit FDA Biologics License Application (BLA) Seeking Approval of CORDStrom for Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ODD/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ODD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODD\",,,,,undefined,":{"symbol":"ODD","market":"US","secType":"STK","nameCN":"ODDITY Tech Ltd.","latestPrice":72.275,"timestamp":1749844800000,"preClose":73.99,"halted":0,"volume":858719,"hourTrading":{"tag":"盘后","latestPrice":72.275,"preClose":72.275,"latestTime":"17:54 EDT","volume":34660,"amount":2505027.195,"timestamp":1749851648341},"delay":0,"floatShares":38704922,"shares":55828291,"eps":1.736982,"marketStatus":"Market Closed","change":-1.715,"latestTime":"06-13 16:00:00 EDT","open":72.5,"high":73.86,"low":71.0801,"amount":62108509.002670005,"amplitude":0.037571,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.736982,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"listingDate":1689739200000,"exchange":"NASDAQ","adjPreClose":73.99,"preHourTrading":{"tag":"盘前","latestPrice":72,"preClose":73.99,"latestTime":"09:29 EDT","volume":2335,"amount":167094.86495,"timestamp":1749821395076},"postHourTrading":{"tag":"盘后","latestPrice":72.275,"preClose":72.275,"latestTime":"17:54 EDT","volume":34660,"amount":2505027.195,"timestamp":1749851648341},"volumeRatio":0.43898084332611054,"impliedVol":0.6025,"impliedVolPercentile":0.44},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODD\",,,,,undefined,":{"symbol":"ODD","floatShares":38704922,"roa":"14.35%","roe":"32.25%","lyrEps":1.769608,"volumeRatio":0.43898084332611054,"shares":55828291,"dividePrice":0,"high":73.86,"amplitude":0.037571,"preClose":73.99,"low":71.0801,"week52Low":32.71,"pbRate":"12.24","psRate":"5.74","week52High":79.1804,"institutionHeld":0,"latestPrice":72.275,"eps":1.736982,"divideRate":0,"volume":858719,"delay":0,"ttmEps":1.736982,"open":72.5,"prevYearClose":42.02,"prevWeekClose":77.35,"prevMonthClose":74.43,"prevQuarterClose":43.26,"fiveDayClose":77.35,"twentyDayClose":63.25,"sixtyDayClose":43.75},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ODD\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514040182","title":"ODDITY Tech Reports $103 Million Remaining in $150 Million Share Buyback Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2514040182","media":"MT Newswires Live","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514040182?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:30","pubTimestamp":1740522641,"startTime":"0","endTime":"0","summary":"ODDITY Tech Reports $103 Million Remaining in $150 Million Share Buyback Authorization","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODD","BK4183"],"gpt_icon":0},{"id":"2514408410","title":"Earnings Flash (ODD) ODDITY Tech Q4 Revenue of $123.6 Million vs. FactSet Est $119.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514408410","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514408410?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:24","pubTimestamp":1740522281,"startTime":"0","endTime":"0","summary":"Earnings Flash (ODD) ODDITY Tech Q4 Revenue of $123.6 Million vs. FactSet Est $119.6 Million","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODD"],"gpt_icon":0},{"id":"2514025582","title":"Oddity Tech (ODD) Tops Q4 Earnings and Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514025582","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514025582?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:15","pubTimestamp":1740521707,"startTime":"0","endTime":"0","summary":"Oddity Tech  came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 53.85%. A quarter ago, it was expected that this online retailer of cosmetics and beauty products would post earnings of $0.22 per share when it actually produced earnings of $0.32, delivering a surprise of 45.45%.Oddity Tech , which belongs to the Zacks Internet - Software industry, posted revenues of $123.64 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 3.17%. This compares to year-ago revenues of $97.25 million. The company has topped consensus revenue estimates four times over the last four quarters.Oddity Tech shares have added about 2.7% since the beginning of the year versus the S&P 500's gain of 1.7%.While Oddity Tech has outperformed the market so far t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oddity-tech-odd-tops-q4-221507620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ODD"],"gpt_icon":0},{"id":"2514047389","title":"Oddity Tech Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2514047389","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514047389?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:00","pubTimestamp":1740520849,"startTime":"0","endTime":"0","summary":"Oddity Tech Ltd reports results for the quarter ended December 31 - Earnings SummaryOddity Tech Ltd ODD.OQ reported quarterly adjusted earnings of 20 cents per share for the quarter ended December 31,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL5N3PG2T7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD"],"gpt_icon":0},{"id":"2514042605","title":"Earnings Flash (ODD) ODDITY Tech Q4 Adjusted EPS $0.20 vs. FactSet Est EPS of $0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2514042605","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514042605?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:47","pubTimestamp":1740520029,"startTime":"0","endTime":"0","summary":"Earnings Flash (ODD) ODDITY Tech Q4 Adjusted EPS $0.20 vs. FactSet Est EPS of $0.13","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODD"],"gpt_icon":0},{"id":"2514426360","title":"Oddity sees FY25 EPS  $1.94-$1.98, consensus $1.73","url":"https://stock-news.laohu8.com/highlight/detail?id=2514426360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514426360?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:45","pubTimestamp":1740519929,"startTime":"0","endTime":"0","summary":"ODDITY (ODD) is providing the following guidance for the year ending December 31, 2025: Net revenue between $776 million and $785 million. Gross ma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oddity-sees-fy25-eps-1-94-1-98-consensus-1-73?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oddity-sees-fy25-eps-1-94-1-98-consensus-1-73?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ODD"],"gpt_icon":0},{"id":"1134187284","title":"Stock Track | ODDITY Tech Soars 5.89% After Record Q4 Revenue and Profits","url":"https://stock-news.laohu8.com/highlight/detail?id=1134187284","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134187284?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:28","pubTimestamp":1740518910,"startTime":"0","endTime":"0","summary":"ODDITY Tech Ltd.  saw its shares surge 5.89% in afternoon trading on Tuesday following the company's report of record fourth quarter and full year 2024 financial results.The beauty and wellness tech firm posted Q4 net revenue of $124 million, up 27% year-over-year, fueled by strong growth in its online direct-to-consumer sales. It was the eighth consecutive quarter that ODDITY exceeded its revenue guidance.ODDITY's adjusted EBITDA for Q4 came in at $15 million, beating the high end of its guidan","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | ODDITY Tech Soars 5.89% After Record Q4 Revenue and Profits","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ODD"],"gpt_icon":0},{"id":"2514547044","title":"ODDITY Tech Q4 2024 Adj EPS $0.20 Beats $0.13 Estimate, Sales $124.00M Beat $119.63M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2514547044","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514547044?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:24","pubTimestamp":1740518669,"startTime":"0","endTime":"0","summary":"ODDITY Tech (NASDAQ:ODD) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.13 by 53.85 percent. This is a 17.65 percent increase over earnings of $0.17 per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43957586/oddity-tech-q4-2024-adj-eps-0-20-beats-0-13-estimate-sales-124-00m-beat-119-63m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD"],"gpt_icon":0},{"id":"2514443430","title":"Oddity Tech: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2514443430","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514443430?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:17","pubTimestamp":1740518233,"startTime":"0","endTime":"0","summary":"TEL AVIV-JAFFA, Israel  — TEL AVIV-JAFFA, Israel  — Oddity Tech Ltd.  on Tuesday reported fourth-quarter earnings of $5.3 million.The Tel aviv-Jaffa, Israel-based company said it had net income of 9 cents per share. Earnings, adjusted for one-time gains and costs, were 20 cents per share.The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 13 cents per share.The online retailer of cosmetics and beauty products posted revenue of $123.6 million in the period.For the year, the company reported profit of $101.5 million, or $1.64 per share. Revenue was reported as $647 million.For the current quarter ending in March, Oddity Tech expects its per-share earnings to range from 61 cents to 63 cents.The company said it expects revenue in the range of $258 million to $262 million for the fiscal first quarter.Oddity Tech expects full-year earnings in the range of $1.94 to $1.98 per share, with revenue ranging ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oddity-tech-q4-earnings-snapshot-211713243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ODD"],"gpt_icon":0},{"id":"2514499970","title":"Oddity Tech Outlook FY Adjusted EPS USD 1.94-1.98","url":"https://stock-news.laohu8.com/highlight/detail?id=2514499970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514499970?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:01","pubTimestamp":1740517277,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nPLX42DCF9:14","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ODD","BK4183"],"gpt_icon":0},{"id":"2514004994","title":"Oddity Tech Q4 Gross Margin 72.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514004994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514004994?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:01","pubTimestamp":1740517277,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nPLX42DCF9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ODD"],"gpt_icon":0},{"id":"2513219476","title":"IPO Stock Of The Week: AI Leader Oddity Shows Buy Point Ahead Of Q4 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2513219476","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513219476?lang=en_us&edition=fundamental","pubTime":"2025-02-22 03:00","pubTimestamp":1740164421,"startTime":"0","endTime":"0","summary":"AI stock Oddity is approaching a new buy point ahead of next week's fourth-quarter earnings report. Oddity stock is at a key level.","market":"us","thumbnail":"https://www.investors.com/wp-content/uploads/2023/08/Stock-OddityTechnology-01-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2023/08/Stock-OddityTechnology-01-adobe-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/stock-lists/ipo-analysis/ai-stock-oddity-stock-odd-earnings/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4183","ODD"],"gpt_icon":0},{"id":"2512682163","title":"US Stocks That Might Be Trading At A Discount In February 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512682163","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512682163?lang=en_us&edition=fundamental","pubTime":"2025-02-18 22:02","pubTimestamp":1739887346,"startTime":"0","endTime":"0","summary":"As the U.S. stock market approaches record highs, with major indices like the S&P 500 and Nasdaq Composite showing strong gains, investors are keenly observing opportunities that may still be trading at a discount. In this environment of optimism and speculation, identifying undervalued stocks requires a careful analysis of fundamentals and potential growth prospects amidst prevailing market conditions.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Overview: Shake Shack Inc. owns, operates, and licenses Shake Shack restaurants in the United States and internationally, with a market cap of approximately $4.61 billion.Operations: The company's revenue primarily comes from its owned and operated restaurants, generating approximately $1.21 billion.Shake Shack's stock is trading at US$108.40, below its estimated fair value of US$133.26, suggesting potential undervaluation based on cash flows. Earnings are expected to grow significantly over the next three years, outpaci","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/us-stocks-might-trading-discount-140226448.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4209","IE00B7SZL793.SGD","ODD","BK4211","BK4153","SHAK","BK4585","CSTM","IE00B19Z4B17.USD","IE0031619046.USD","IE00B66KJ199.SGD","KD","BK4195","VIK","BK4134","BK4183","BK4142","BK4588","PFS"],"gpt_icon":0},{"id":"2512978635","title":"Top Growth Companies With High Insider Ownership On US Exchanges February 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512978635","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512978635?lang=en_us&edition=fundamental","pubTime":"2025-02-17 23:02","pubTimestamp":1739804554,"startTime":"0","endTime":"0","summary":"As the U.S. stock market continues to hover near record highs, with major indexes posting weekly gains, investors are keenly observing growth companies that demonstrate resilience and potential in a fluctuating economic landscape. In this context, high insider ownership can be a promising indicator of confidence in a company's future performance, particularly when combined with robust growth prospects.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2062000-choice2-main-header/1585186653417","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2062000-choice2-main-header/1585186653417"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-magn/magnera/news/top-growth-companies-with-high-insider-ownership-on-us-excha-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4113","BK4199","ODD","BK4547","BK4585","LU2265009873.SGD","BK4183","BK4526","MAGN","BK4588","TBBB","ONON","BK4146","CSIQ","BK4141","BK4519","LU1804176565.USD"],"gpt_icon":1},{"id":"2511758009","title":"ODDITY to Announce Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2511758009","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511758009?lang=en_us&edition=fundamental","pubTime":"2025-02-13 05:05","pubTimestamp":1739394300,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 12, 2025  -- ODDITY Tech Ltd.  , today announced that it will release its fourth quarter and full year 2024 financial results after the market close on Tuesday, February 25, 2025, to be followed by a conference call on Wednesday, February 26, 2025, at 8:30 a.m. Eastern Time.ODDITY is a consumer tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company serves approximately 50 million users with its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. ODDITY owns IL MAKIAGE and SpoiledChild. The company operates with business headquarters in New York City, an R&D center in Tel Aviv, Israel, and a biotechnology lab in Boston.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oddity-announce-fourth-quarter-full-210500996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4183","ODD"],"gpt_icon":0},{"id":"2511301587","title":"Rare opportunities – ASX health stocks tackling unmet medical needs","url":"https://stock-news.laohu8.com/highlight/detail?id=2511301587","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511301587?lang=en_us&edition=fundamental","pubTime":"2025-02-13 04:05","pubTimestamp":1739390731,"startTime":"0","endTime":"0","summary":"There are significant incentives for pharmaceutical companies to develop treatments for rare diseases. Neurizon is focused on paediatric neurological disorders where there is inflammation, including rare diseases. Dimerix is focused on the rare kidney disease focal segmental glomerulosclerosis ","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/02/GettyImages-2190666371-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/02/GettyImages-2190666371-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/rare-opportunities-asx-health-stocks-tackling-unmet-medical-needs/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4183","ODD","FSGS"],"gpt_icon":0},{"id":"2510383533","title":"Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia","url":"https://stock-news.laohu8.com/highlight/detail?id=2510383533","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510383533?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:30","pubTimestamp":1739277000,"startTime":"0","endTime":"0","summary":"Spinocerebellar Ataxia  is a rare, genetic, life-threatening neurodegenerative disease with no available treatment.Troriluzole demonstrated a 50-70% slowing of SCA disease progression on the primary and secondary outcome measures at the 3-year endpoint in a real-world evidence  study.Troriluzole has a well-established safety profile and if approved, would be the first and only FDA-approved treatment for SCA; subject to receipt of FDA approval, Biohaven is prepared to commercialize troriluzole for SCA in the US in 2025.The NDA submission was based, in part, on positive topline results from Study BHV4157-206-RWE , in which troriluzole 200 mg dosed orally in patients with SCA met the study's primary endpoint of change from baseline on the functional Scale for the Assessment and Rating of Ataxia , in all SCA genotypes, at 3 years compared to an external control arm. Troriluzole showed statistically sig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biohaven-announces-fda-acceptance-priority-123000967.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biohaven-announces-fda-acceptance-priority-123000967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BHVN","BK4183","LU1093756325.SGD","SCA","PSM","BK4139","LU1093756168.USD","ODD"],"gpt_icon":0},{"id":"2510865439","title":"Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865439","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510865439?lang=en_us&edition=fundamental","pubTime":"2025-02-10 22:35","pubTimestamp":1739198100,"startTime":"0","endTime":"0","summary":"FDA RMAT designation follows positive proof-of-concept U.S. clinical data from the NXC-201 NEXICART-2 clinical trial in relapsed/refractory AL AmyloidosisRMAT designation potentially streamlines the p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/10/3023535/0/en/Immix-Biopharma-Receives-FDA-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-for-NXC-201-sterically-optimized-CAR-T-for-relapsed-refractory-AL-Amyloidosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","AL","BK4157","IE00B19Z6F94.USD","BK4104","BK4572","BK4230","IE00B19Z4B17.USD","CAR","NXC","IE00B7SZL793.SGD","ODD","BK4022","IE00B66KJ199.SGD","BK4183","IE0034390439.USD","AEIS"],"gpt_icon":0},{"id":"2510658854","title":"Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2510658854","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510658854?lang=en_us&edition=fundamental","pubTime":"2025-02-10 21:00","pubTimestamp":1739192400,"startTime":"0","endTime":"0","summary":"Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif., Feb. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/10/3023370/0/en/Tempest-Granted-Fast-Track-Designation-from-the-U-S-Food-and-Drug-Administration-for-Amezalpat-to-Treat-Patients-with-Hepatocellular-Carcinoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5TLWC47.USD","BK4203","BK4097","ODD","BK4104","BK4585","HR","BK4183","IE00BFXG0V08.USD","BK4225","BK4588","IE00BYQQ9H92.USD","OS","BK4567","FAST","ALD","HCC","BK4006"],"gpt_icon":0},{"id":"2510855226","title":"INmune Bio Announces Plan to Submit FDA Biologics License Application (BLA) Seeking Approval of CORDStrom for Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510855226","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510855226?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:00","pubTimestamp":1739188800,"startTime":"0","endTime":"0","summary":"The Company reports results of a double-blinded, randomized, placebo-controlled study, known as “MissionEB,” investigating CORDStrom for treatment of RDEB in pediatric patients, which evidence a favorable benefit-risk profile in support of the intended applications for marketing authorization.CORDStrom, developed by INmune Bio is a patent pending, off the shelf, advanced mesenchymal stromal cell  platform developed to treat complex inflammatory diseases that has significant clinical development advantages over current MSC products.FDA grants CORDStrom a Rare Pediatric Disease Designation  and Orphan Drug Designation  for treatment of epidermolysis bullosa .The MissionEB study, led by Dr. Anna Martinez and team at the Great Ormond Street Hospital  in collaboration with clinicians from Birmingham’s Children’s Hospital, was a double blind, placebo-controlled, cross-over study evaluating the safety and efficacy of CORDStrom in 30 pediatric patients  in the UK with intermediate or severe RD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inmune-bio-announces-plan-submit-120000449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INMB","BK4183","BK4215","BK4575","ODD","BK4108","BK4150","MSC","BK4139","EB","BK4585","MAA","BK4588","BK4077"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":6,"totalSize":164,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ODD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-29","symbol":"ODD","fiscalQuarterEnding":"2025/03","expectedEps":0.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"post","actualEps":0.63},{"market":"US","date":"2025-02-25","symbol":"ODD","fiscalQuarterEnding":"2024/12","expectedEps":0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":0.06},{"market":"US","date":"2024-11-06","symbol":"ODD","fiscalQuarterEnding":"2024/09","expectedEps":0.16,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":0.29},{"market":"US","date":"2024-08-07","symbol":"ODD","fiscalQuarterEnding":"2024/06","expectedEps":0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":0.71},{"market":"US","date":"2024-05-07","symbol":"ODD","fiscalQuarterEnding":"2024/03","expectedEps":0.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"post","actualEps":0.53}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ODD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ODD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.5556,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1738382400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ODD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ODD","date":"2025-06-13","current":38.84497,"percent":0.738758,"low":20.831575,"twenty":24.888137,"median":31.181916,"eighty":42.353632,"high":144.174884,"avg":34.927998,"sd":17.317062,"marketCap":4130735251},"quantilePoints":[{"date":"2023-07-21","current":130.121737,"twenty":124.979326,"median":126.90773,"eighty":128.836134,"marketCap":2827285100},{"date":"2023-07-28","current":127.857619,"twenty":126.192061,"median":128.560276,"eighty":129.606455,"marketCap":2778090339},{"date":"2023-08-04","current":144.174884,"twenty":128.138682,"median":130.121737,"eighty":138.668132,"marketCap":3132631890},{"date":"2023-08-11","current":59.921033,"twenty":128.138682,"median":131.59899,"eighty":138.150305,"marketCap":3096718967},{"date":"2023-08-18","current":49.805463,"twenty":52.028567,"median":129.262933,"eighty":135.506534,"marketCap":2573946329},{"date":"2023-08-25","current":45.155781,"twenty":48.598524,"median":91.807378,"eighty":132.13135,"marketCap":2333650744},{"date":"2023-09-01","current":45.716381,"twenty":47.266275,"median":50.709145,"eighty":131.711973,"marketCap":2362622552},{"date":"2023-09-08","current":40.286255,"twenty":46.134083,"median":49.805463,"eighty":131.410685,"marketCap":2081993665},{"date":"2023-09-15","current":40.648996,"twenty":43.649855,"median":48.206104,"eighty":130.121737,"marketCap":2100740129},{"date":"2023-09-22","current":30.701094,"twenty":40.692965,"median":47.574055,"eighty":129.262933,"marketCap":1586632553},{"date":"2023-09-29","current":31.151773,"twenty":36.878686,"median":46.562777,"eighty":127.857619,"marketCap":1609923614},{"date":"2023-10-06","current":28.491671,"twenty":32.503808,"median":45.749357,"eighty":123.693723,"marketCap":1472449544},{"date":"2023-10-13","current":31.976185,"twenty":32.503808,"median":44.402818,"eighty":59.921033,"marketCap":1652529215},{"date":"2023-10-20","current":29.832714,"twenty":31.459553,"median":41.803173,"eighty":57.306257,"marketCap":1541754654},{"date":"2023-10-27","current":29.832714,"twenty":31.15617,"median":40.714949,"eighty":54.667412,"marketCap":1541754654},{"date":"2023-11-03","current":29.678824,"twenty":30.355941,"median":40.467625,"eighty":50.479578,"marketCap":1533801609},{"date":"2023-11-10","current":30.298177,"twenty":30.305454,"median":36.878686,"eighty":50.003322,"marketCap":1598562121},{"date":"2023-11-17","current":37.221321,"twenty":30.355941,"median":36.411519,"eighty":49.783479,"marketCap":1963834134},{"date":"2023-11-24","current":37.016749,"twenty":30.445709,"median":37.119035,"eighty":49.462508,"marketCap":1953040715},{"date":"2023-12-01","current":36.693741,"twenty":30.5941,"median":37.016749,"eighty":48.26876,"marketCap":1935998475},{"date":"2023-12-08","current":40.591374,"twenty":30.734071,"median":37.17287,"eighty":48.041138,"marketCap":2141641505},{"date":"2023-12-15","current":46.060981,"twenty":30.923136,"median":37.910406,"eighty":47.753992,"marketCap":2430223438},{"date":"2023-12-22","current":50.712301,"twenty":31.153971,"median":38.59949,"eighty":48.041138,"marketCap":2675631695},{"date":"2023-12-29","current":50.884572,"twenty":31.160567,"median":38.868664,"eighty":49.761494,"marketCap":2684720890},{"date":"2024-01-05","current":46.7716,"twenty":31.28148,"median":39.765881,"eighty":49.183424,"marketCap":2467716366},{"date":"2024-01-12","current":46.965405,"twenty":31.46395,"median":40.526773,"eighty":48.323896,"marketCap":2477941710},{"date":"2024-01-19","current":45.899477,"twenty":31.472743,"median":40.645209,"eighty":48.306372,"marketCap":2421702318},{"date":"2024-01-26","current":45.684138,"twenty":31.580467,"median":40.703957,"eighty":48.306372,"marketCap":2410340824},{"date":"2024-02-02","current":45.156558,"twenty":31.989432,"median":42.12028,"eighty":48.252127,"marketCap":2382505165},{"date":"2024-02-09","current":48.246671,"twenty":32.113484,"median":43.346019,"eighty":48.217673,"marketCap":2545542596},{"date":"2024-02-16","current":46.125583,"twenty":32.418946,"median":44.467474,"eighty":48.217673,"marketCap":2433631886},{"date":"2024-02-23","current":42.389454,"twenty":32.503808,"median":43.451996,"eighty":48.101679,"marketCap":2236509975},{"date":"2024-03-01","current":45.414965,"twenty":32.586249,"median":43.346019,"eighty":47.880595,"marketCap":2396138958},{"date":"2024-03-08","current":42.187798,"twenty":32.646706,"median":43.451996,"eighty":47.880595,"marketCap":2469420590},{"date":"2024-03-15","current":43.718187,"twenty":32.976471,"median":43.684021,"eighty":47.798976,"marketCap":2559000375},{"date":"2024-03-22","current":43.038127,"twenty":33.910804,"median":43.451996,"eighty":47.751391,"marketCap":2519193702},{"date":"2024-03-28","current":41.755726,"twenty":34.121582,"median":43.229275,"eighty":47.682483,"marketCap":2444129691},{"date":"2024-04-05","current":35.33401,"twenty":34.429566,"median":43.074483,"eighty":47.592295,"marketCap":2068240969},{"date":"2024-04-12","current":35.168853,"twenty":35.003425,"median":42.938568,"eighty":47.491972,"marketCap":2058573635},{"date":"2024-04-19","current":32.672059,"twenty":33.859301,"median":42.736957,"eighty":47.44561,"marketCap":1912426280},{"date":"2024-04-26","current":30.816464,"twenty":32.666988,"median":42.389454,"eighty":47.239294,"marketCap":1803810931},{"date":"2024-05-03","current":32.701204,"twenty":32.521826,"median":42.280345,"eighty":47.139393,"marketCap":1914132280},{"date":"2024-05-10","current":30.051334,"twenty":32.188614,"median":42.12028,"eighty":47.109682,"marketCap":2161502316},{"date":"2024-05-17","current":34.470881,"twenty":32.029175,"median":41.880975,"eighty":47.036466,"marketCap":2479387030},{"date":"2024-05-24","current":28.991908,"twenty":31.962852,"median":41.668069,"eighty":46.979437,"marketCap":2085300972},{"date":"2024-05-31","current":28.39104,"twenty":31.618936,"median":40.692965,"eighty":46.967038,"marketCap":2042082299},{"date":"2024-06-07","current":35.032218,"twenty":31.466148,"median":40.618291,"eighty":46.952485,"marketCap":2519762369},{"date":"2024-06-14","current":31.434913,"twenty":31.466148,"median":40.526773,"eighty":46.846969,"marketCap":2261018998},{"date":"2024-06-21","current":31.17401,"twenty":31.40776,"median":40.286255,"eighty":46.77806,"marketCap":2242252995},{"date":"2024-06-28","current":31.039605,"twenty":31.15617,"median":39.116208,"eighty":46.676851,"marketCap":2232585660},{"date":"2024-07-05","current":32.549682,"twenty":31.153971,"median":38.825596,"eighty":46.51104,"marketCap":2341201009},{"date":"2024-07-12","current":33.300768,"twenty":31.165014,"median":38.233414,"eighty":46.411983,"marketCap":2395224351},{"date":"2024-07-19","current":31.719535,"twenty":31.193823,"median":37.851188,"eighty":46.379683,"marketCap":2281491001},{"date":"2024-07-26","current":32.889648,"twenty":31.177172,"median":37.124419,"eighty":46.315081,"marketCap":2365653680},{"date":"2024-08-02","current":30.43083,"twenty":31.177172,"median":37.016749,"eighty":46.269497,"marketCap":2188798320},{"date":"2024-08-09","current":24.621128,"twenty":31.077829,"median":36.878686,"eighty":46.15167,"marketCap":2152403648},{"date":"2024-08-16","current":25.909103,"twenty":30.914687,"median":36.319047,"eighty":46.132383,"marketCap":2264999665},{"date":"2024-08-23","current":24.744722,"twenty":30.826367,"median":35.664326,"eighty":46.112663,"marketCap":2163208317},{"date":"2024-08-30","current":23.938111,"twenty":30.576415,"median":35.479654,"eighty":46.043754,"marketCap":2092693640},{"date":"2024-09-06","current":21.999645,"twenty":30.415298,"median":35.251431,"eighty":45.974846,"marketCap":1923230948},{"date":"2024-09-13","current":22.858294,"twenty":30.138302,"median":35.032218,"eighty":45.974846,"marketCap":1998294959},{"date":"2024-09-20","current":23.144511,"twenty":29.832714,"median":34.577614,"eighty":45.899477,"marketCap":2023316296},{"date":"2024-09-27","current":25.837549,"twenty":29.733784,"median":34.493388,"eighty":45.749357,"marketCap":2258744331},{"date":"2024-10-04","current":26.907033,"twenty":29.206161,"median":34.203986,"eighty":45.716381,"marketCap":2352239691},{"date":"2024-10-11","current":26.632604,"twenty":28.857503,"median":34.05976,"eighty":45.700078,"marketCap":2328248903},{"date":"2024-10-18","current":26.737148,"twenty":28.675661,"median":33.782046,"eighty":45.684138,"marketCap":2337388251},{"date":"2024-10-25","current":24.829219,"twenty":28.39104,"median":33.498422,"eighty":45.587236,"marketCap":2170595150},{"date":"2024-11-01","current":24.874957,"twenty":27.774359,"median":33.138619,"eighty":45.414965,"marketCap":2174593614},{"date":"2024-11-08","current":25.903059,"twenty":26.907033,"median":32.701204,"eighty":45.328829,"marketCap":2624135294},{"date":"2024-11-15","current":22.412856,"twenty":26.554196,"median":32.64481,"eighty":45.156558,"marketCap":2270556768},{"date":"2024-11-22","current":25.688798,"twenty":26.266873,"median":32.549682,"eighty":45.155781,"marketCap":2602429343},{"date":"2024-11-29","current":26.196259,"twenty":26.231703,"median":32.526331,"eighty":45.078881,"marketCap":2653838175},{"date":"2024-12-06","current":27.019473,"twenty":26.102043,"median":32.510933,"eighty":44.930453,"marketCap":2737234726},{"date":"2024-12-13","current":27.882156,"twenty":26.129486,"median":32.397731,"eighty":44.829243,"marketCap":2824629741},{"date":"2024-12-20","current":24.673876,"twenty":26.102043,"median":32.284642,"eighty":44.80743,"marketCap":2499611678},{"date":"2024-12-27","current":24.555468,"twenty":26.074468,"median":32.122117,"eighty":44.68052,"marketCap":2487616283},{"date":"2025-01-03","current":24.036731,"twenty":26.028044,"median":31.982415,"eighty":44.572573,"marketCap":2435065032},{"date":"2025-01-10","current":24.916329,"twenty":25.91918,"median":31.969518,"eighty":44.533395,"marketCap":2524173675},{"date":"2025-01-17","current":25.299744,"twenty":25.850651,"median":31.948814,"eighty":44.510542,"marketCap":2563015904},{"date":"2025-01-24","current":24.983991,"twenty":25.688798,"median":31.719535,"eighty":44.467474,"marketCap":2531028186},{"date":"2025-01-31","current":26.906704,"twenty":25.660605,"median":31.631647,"eighty":44.252135,"marketCap":2725810541},{"date":"2025-02-07","current":24.025454,"twenty":25.660605,"median":31.600943,"eighty":44.067933,"marketCap":2433922614},{"date":"2025-02-14","current":24.245353,"twenty":25.528357,"median":31.476041,"eighty":43.718187,"marketCap":2456199775},{"date":"2025-02-21","current":24.809199,"twenty":25.393274,"median":31.447233,"eighty":43.663521,"marketCap":2513320700},{"date":"2025-02-28","current":26.194867,"twenty":25.287339,"median":31.363758,"eighty":43.611255,"marketCap":2658543217},{"date":"2025-03-07","current":24.561126,"twenty":25.149762,"median":31.267028,"eighty":43.481918,"marketCap":2492733193},{"date":"2025-03-14","current":25.259729,"twenty":25.127573,"median":31.17401,"eighty":43.282433,"marketCap":2563635122},{"date":"2025-03-21","current":23.829518,"twenty":25.089994,"median":31.105558,"eighty":43.231428,"marketCap":2418481566},{"date":"2025-03-28","current":23.620487,"twenty":25.062794,"median":30.968449,"eighty":43.177394,"marketCap":2397266815},{"date":"2025-04-04","current":20.886583,"twenty":24.97973,"median":30.909153,"eighty":43.121556,"marketCap":2119800209},{"date":"2025-04-11","current":22.872376,"twenty":24.935811,"median":30.865977,"eighty":43.052669,"marketCap":2321340339},{"date":"2025-04-17","current":23.075906,"twenty":24.876099,"median":30.80242,"eighty":42.991494,"marketCap":2341996807},{"date":"2025-04-25","current":24.341093,"twenty":24.812177,"median":30.590011,"eighty":42.947303,"marketCap":2470401876},{"date":"2025-05-02","current":33.211688,"twenty":24.800183,"median":30.612672,"eighty":42.912727,"marketCap":3531697688},{"date":"2025-05-09","current":37.275211,"twenty":24.812177,"median":30.809442,"eighty":42.852836,"marketCap":3963808661},{"date":"2025-05-16","current":33.075187,"twenty":24.823197,"median":30.881482,"eighty":42.719469,"marketCap":3517182333},{"date":"2025-05-23","current":36.009954,"twenty":24.840888,"median":30.917059,"eighty":42.57047,"marketCap":3829262479},{"date":"2025-05-30","current":37.968215,"twenty":24.859184,"median":31.004027,"eighty":42.466444,"marketCap":4037502005},{"date":"2025-06-06","current":40.472479,"twenty":24.875718,"median":31.151773,"eighty":42.376534,"marketCap":4303802953},{"date":"2025-06-13","current":38.84497,"twenty":24.888137,"median":31.181916,"eighty":42.353632,"marketCap":4130735251}],"updateTime":1749944283275}}}